- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT00639535
Study Comparing the PET Scan and MRI in Identifying Breast Malignancies in Women With Breast Abnormalities
Comparative Study of the Diagnostic Accuracy of Scintimammography (Fluorine 18-FDG PET Scintigraphic Imaging) and Magnetic Resonance Imaging in Identifying Malignant Breast Lesions, In Subjects With Breast Abnormalities
This is a study looking at advanced imaging such as PET/CT and MRI to see if they can provide a more accurate assessment of the patient with dense breasts or difficult to interpret mammograms. In addition, the ability to determine whether one or the other is more accurate or whether both together would be appropriate in this clinical situation, may be able to be measured.
The MRI studies are very sensitive for detection of breast histopathology but less specific in differentiating between small low grade malignancies are more benign pathologies. Multifocal pathology can be challenging in determining site(s) for biopsy.
PET scanning is specific in the measurement of metabolic glucose activity of various histopathologies and is accurate in differentiating aggressive from benign pathology in multifocal breast disease. A further drawback of PET is the lack of ability to observe lesions less than 3-4mm in diameter.
In select cases the combination of MR and PET/CT is able to come to a more conclusive diagnosis - specifically with bilateral or multifocal breast disease.
Study Overview
Status
Conditions
Study Type
Enrollment (Actual)
Contacts and Locations
Study Locations
-
-
New York
-
Liverpool, New York, United States, 13088
- Central New York PET Center
-
Syracuse, New York, United States, 13202
- University Radiology Associates
-
Syracuse, New York, United States, 13210
- Institute For Human Performance
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Sampling Method
Study Population
Description
Inclusion Criteria:
- Woman who have breast volumes allowing utilization of MRI breast coil
- Patients who are considered, by radiologist reading the mammograms, to have non interpretable or difficult to interpret x-ray studies. These patients may or may not have palpable breast lumps and may and may not have suspicious areas on their x-ray mammograms.
Exclusion Criteria:
- Women of child bearing potential not practicing a medically accepted method of birth control
- Women who are pregnant or breast-feeding
Study Plan
How is the study designed?
Design Details
Collaborators and Investigators
Investigators
- Principal Investigator: David Feiglin, MD, State University of New York - Upstate Medical University
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Estimated)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- SUNYUMU 4493
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Breast Disease
-
Jose Ignacio SánchezWelwaze Medical Inc.Enrolling by invitationBreast Cancer | Benign Breast Disease | Breast DiseaseSpain
-
Assistance Publique - Hôpitaux de ParisInstitut PasteurCompleted
-
Zedsen LimitedImperial College Healthcare NHS TrustRecruitingBreast Cancer | Benign Breast DiseaseUnited Kingdom
-
Brigham and Women's HospitalBreast Cancer Research Foundation; Partners in Health; Rwanda Biomedical CentreCompletedBreast Cancer | Benign Breast DiseaseRwanda
-
Tensive SRLCompleted
-
National Cancer Institute (NCI)CompletedBenign Breast DiseaseUnited States
-
Seoul National University HospitalActive, not recruitingBreast Cancer | Breast Neoplasm | Ultrasonography | Artificial Intelligence | Benign Breast DiseaseKorea, Republic of
-
Brigham and Women's HospitalNational Cancer Institute (NCI)Active, not recruitingBenign Breast DiseaseUnited States
-
University of MichiganWayne State UniversityCompleted
-
Alexandria UniversityCompletedBenign Breast Disease | Duct Ectasia BreastEgypt